Envoy Medical, Inc. (COCH)

Envoy Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-19.52	-20.8	-29.92	-15.92	-8.68
Depreciation & Amortization	0.2	0.17	0.13	0.08	0.07
Other Amortization	1.02	1.05	0.6	-	-
Loss (Gain) From Sale of Assets	-	-	-	-	0
Stock-Based Compensation	0.6	0.56	1.58	-	-
Other Operating Activities	0.13	1.7	11.5	7.2	1.75
Change in Accounts Receivable	0.15	0.03	-0.03	0.05	-0.02
Change in Inventory	-0.17	-0.38	-0.01	-0.19	0.06
Change in Accounts Payable	0.63	-0.02	0.55	0.34	0.23
Change in Other Net Operating Assets	0.87	-0.27	-1.5	-0.36	-0.35
Operating Cash Flow	-16.09	-17.95	-17.09	-8.81	-6.94
Capital Expenditures	-0.88	-0.98	-0.15	-0.22	-0.13
Investing Cash Flow	-0.88	-0.98	-0.15	-0.22	-0.13
Long-Term Debt Issued	-	20	10	8	8
Long-Term Debt Repaid	-	-0.92	-0.56	-	-
Net Debt Issued (Repaid)	19.11	19.08	9.44	8	8
Issuance of Common Stock	0.06	1.75	0.11	-	-
Preferred Dividends Paid	-3.66	-2.45	-	-	-
Dividends Paid	-3.66	-2.45	-	-	-
Other Financing Activities	1.82	1.82	11.74	0.09	0.06
Financing Cash Flow	17.33	20.2	21.28	8.09	8.06
Foreign Exchange Rate Adjustments	0	-0.01	-0	-0.01	-0.01
Miscellaneous Cash Flow Adjustments	0	0	-	-	-
Net Cash Flow	0.37	1.27	4.04	-0.94	0.99
Free Cash Flow	-16.96	-18.93	-17.24	-9.02	-7.06
Free Cash Flow Margin	-8000.94%	-8412.89%	-5456.96%	-3807.17%	-2277.74%
Free Cash Flow Per Share	-0.87	-1.01	-1.40	-0.89	-0.70
Levered Free Cash Flow	-11.63	-12.14	-5.91	-5.17	-
Unlevered Free Cash Flow	-10.83	-11.63	-5.91	-5.17	-
Change in Net Working Capital	-0.4	0.4	-3.41	-0.41	-

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q